Evaluation of Drug Blood-Brain-Barrier Permeability Using a Microfluidic Chip.
Jung Yoon YangDae-Seop ShinMoonkyu JeongSeong Soon KimHa Neul JeongByung Hoi LeeKyu-Seok HwangYuji SonHyeon-Cheol JeongChi-Hoon ChoiKyeong-Ryoon LeeMyung Ae BaePublished in: Pharmaceutics (2024)
The blood-brain-barrier (BBB) is made up of blood vessels whose permeability enables the passage of some compounds. A predictive model of BBB permeability is important in the early stages of drug development. The predicted BBB permeabilities of drugs have been confirmed using a variety of in vitro methods to reduce the quantities of drug candidates needed in preclinical and clinical trials. Most prior studies have relied on animal or cell-culture models, which do not fully recapitulate the human BBB. The development of microfluidic models of human-derived BBB cells could address this issue. We analyzed a model for predicting BBB permeability using the Emulate BBB-on-a-chip machine. Ten compounds were evaluated, and their permeabilities were estimated. Our study demonstrated that the permeability trends of ten compounds in our microfluidic-based system resembled those observed in previous animal and cell-based experiments. Furthermore, we established a general correlation between the partition coefficient (Kp) and the apparent permeability (Papp). In conclusion, we introduced a new paradigm for predicting BBB permeability using microfluidic-based systems.
Keyphrases
- blood brain barrier
- endothelial cells
- circulating tumor cells
- high throughput
- single cell
- cerebral ischemia
- clinical trial
- emergency department
- cell therapy
- label free
- magnetic resonance
- induced pluripotent stem cells
- magnetic resonance imaging
- stem cells
- cell proliferation
- deep learning
- oxidative stress
- cell death
- bone marrow
- case control
- study protocol
- adverse drug
- open label
- cell cycle arrest